阿帕替尼作为晚期肺癌二线或后期治疗的疗效及不良反应

{"title":"阿帕替尼作为晚期肺癌二线或后期治疗的疗效及不良反应","authors":"Tao Ren, Yan Wu","doi":"10.1007/s10330-020-0468-8","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":345149,"journal":{"name":"Oncology and Translational Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and adverse reactions of apatinib as second-line or later-line treatment in advanced lung cancer\",\"authors\":\"Tao Ren, Yan Wu\",\"doi\":\"10.1007/s10330-020-0468-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":345149,\"journal\":{\"name\":\"Oncology and Translational Medicine\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology and Translational Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s10330-020-0468-8\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology and Translational Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10330-020-0468-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}